Skip to content

Clinical trials

Osteosarcoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteosarcoma Country / region: Italy Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20081
20112
20131
20142
20161
20172
20181
20203
20214
20222
20233
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting6
Terminated4
Active, not recruiting2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Istituto Ortopedico Rizzoli7
Italian Sarcoma Group7
Eli Lilly and Company2
Bambino Gesù Hospital and Research Institute1
Celgene1
Eisai Inc.1
Eisai Limited1
GlaxoSmithKline1
Grupo Espanol de Investigacion en Sarcomas1
Gustave Roussy, Cancer Campus, Grand Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteosarcoma28
Sarcoma, Ewing8
Sarcoma6
Bone Neoplasms4
Melanoma3
Neuroblastoma3
Rhabdomyosarcoma3
Chondrosarcoma2
Diffuse Intrinsic Pontine Glioma2
Ependymoma2

Trials

Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.